Welcome BioPorto!

PT Genetika Science would like to welcome BioPorto as our new partner!

BioPorto Diagnostics focus on developing and licensing antibodies and antibody-based products aimed at the basic research market segment. Recently, BioPorto Diagnostics launched a groundbreaking test called NGAL that can diagnose acute kidney injury. With the NGAL test, the occurrence of kidney injury can now be revealed within a few hours!

BioPorto’s strategy is to develop new methods based on its antibody portfolio that can be patented and achieve a wide use in the diagnosis of various diseases. In addition, BioPorto Diagnostics A/S offers a range of antibodies under the AntibodyShop® brand. With this partnership, we hope to bring high quality research products to our valued customers!

Welcome onboard, Kapa Biosystems!

PT Genetika Science welcomes Kapa Biosystems with effect from February 2009. We can better meet the needs of our molecular biology customers with Kapa Biosystems’ range of innovative Next Generation PCR Reagents.

Next-generation PCR is defined as the shift from generalist wild-type enzymes toward designer specialist enzymes. Kapa Biosystems’ next-gen PCR reagents are fundamentally different at the protein level; our engineered polymerases contain unique amino acid modifications that confer dramatic improvements to the function of the enzyme.

This transition is made possible by Kapa Biosystems’ powerful protein engineering platform. This platform is being used to develop a portfolio of designer polymerases engineered specifically for applications such as qPCR, Fast PCR, high fidelity PCR, crude sample PCR, next-generation DNA sequencing, and molecular diagnostics. Look out for our Product Spotlights on Kapa Biosystems’ leading reagents!

Welcome onboard, Glycosan Biosystems!

PT Genetika Science distributes Glycosan Biosystems with effect from February 2009. Specializing in biocompatible, optimizable hydrogel matrices for general 3-D and stem cell culture, ExtracelTM and HyStemTM, Glycosan Biosystems provide a sophisticated range of biomolecules to meet the demanding needs of cell culture.

Glycosan BioSystems holds exclusive worldwide rights to a patent estate, which was licensed from the University of Utah Research Foundation with broad claims to product chemical composition, method of crosslinking, method of preparation, and use of the synthetic extracellular matrix (sECM).

The exclusive sECM technology behind Glycosan’s Extracel™ product line makes several specific applications possible, including:

• in vitro three-dimensional cell culture
• in vitro and in vivo animal models to screen for drug efficacy, safety, and toxicology
• reagents for tissue and cell preservation
• personal-care products

Glycosan also holds a co-exclusive license for tissue engineering and cell-therapy applications of Extracel™.

Glycosan BioSystems manufactures ExtracelTM and HyStemTM lines of biocompatible, optimizable hydrogel matrices for general 3-D and stem cell culture. The foundation for both lines is thiol-modified hyaluronic acid which allows a variety of thiol-modified proteins, peptides, or small molecules to be easily crosslinked into the hydrogel. The Extracel line is specifically designed for general and 3-D cell culture. The HyStem line is designed for stem cell culture and transplantation, providing the bridge between cell culture and cell therapy.

PT Genetika Science signs on Biomatrica!

We are pleased to announce that with effect from February 2009, PT Genetika Science has been appointed as Biomatrica’s distributor in Indonesia. We look forward to bringing innovative and advanced sample stabilization solutions to our customers.

Biomatrica® develops and offers innovative technologies for stabilizing biological materials at room temperature. Biomatrica's stabilization technology allows for storage of samples outside cold environments (4ºC, -20ºC, -80ºC and liquid nitrogen) while preserving sample integrity, thus greatly reducing costs and reliance on maintaining cold conditions during shipment and storage.

Biomatrica® has developed a novel core technology designed to prevent the degradation of complex samples, reagents and assays during transport, storage and processing, thus allowing scientists to:

• obtain more reproducible and reliable experimental results
• increase efficiency and confidence
• decrease time needed to obtain results

Their current products stabilize nucleic acids and prevent degradation without the need for cold storage:

• DNA SampleMatrix®
• RNAstable™
• CloneStable™ for bacterial DNA

Biomatrica also currently offers the following solutions to leverage and complement the stabilization product portfolio:

• PCRboost™, an enhancing reagent for end-point and reverse transcription-PCR.
• SampleWare® software, an easy-to-use, customizable laboratory management database to store and organize sample data.

Biomatrica's products are expected to improve research within a broad scope of laboratories involved in life sciences research, healthcare diagnostics, drug development and forensics.